Redeye leaves a short comment on Stille following the company's announcement that the CEO will resig...
Redeye leaves a comment following Magle’s recent announcement of a directed share issue of approxima...
Redeye returns with an updated view of Saniona following the Q3 report and the transformative licens...
Biovica records another quarter of modest quarterly IVD test sales growth of 50-55% (compared with t...
Redeye comments on the recently announced USD155m fundraising by Ayar Labs, a key partner of Sivers ...
Kostnaderna för att stöpa om koncernen kulminerade sannolikt under det säsongsmässigt svaga Q3, samt...
Biovica records IVD test sales in Q2 of SEK 0.97m , which is 54% above the previous quarter (Q1) and...
The company downgraded its full year 2024 net sales guidance midpoint by 4% and EBIT guidance midpoi...
Förvärvet av TrustPlay, med tillhörande teknikportfölj, positionerar Tangiamo i framkant av den växa...
Redeye comments on the press release from Moberg Pharma last night.
The somewhat weak Q3 situation continues in Q4 2024.
Enersense has extended its telecom network service contract, including construction services, with T...
After market close on 9 December, Husqvarna issued a profit warning due to challenging market condit...
Gapwaves has received an order from a new North American Tier-1 for Gapwaves MLW waveguide antenna i...
Redeye leaves a comment following Alzinova’s announced study results form the phase Ib extension stu...
